Keyphrases
Cancer Cells
100%
Anticancer Agents
100%
Aldehyde Dehydrogenase 2 (ALDH2)
100%
Effects on Humans
100%
Kinetic Effects
100%
Kinetic Characterization
100%
ALDH1A3
27%
Cancer Therapy
18%
ALDH1A2
18%
Aldehyde Dehydrogenase Activity
18%
WIN 18,446
18%
Non-competitive
9%
Inhibitory Activity
9%
Cancer Stem Cells
9%
NADP+
9%
Drug Target
9%
Cell Survival
9%
Carboxylic Acids
9%
Aldehydes
9%
Recombinant Protein
9%
Reductase Inhibitors
9%
A549 Cells
9%
Retinaldehyde
9%
Acetic Acid Derivative
9%
Aldo-keto Reductase
9%
Pyrimido
9%
Retinoic Acid Signaling
9%
Potent Inhibitor
9%
Enzyme Inhibitors
9%
IC50 Value
9%
Quinoline
9%
Cancer Cell Viability
9%
A549 Lung Cancer Cells
9%
Potential Drugs
9%
Promising Drug
9%
Thiazolidinediones
9%
Novel Combination Therapy
9%
Chemoresistance
9%
Drug Inactivation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Anticarcinogen
100%
Aldehyde Dehydrogenase
100%
Carboxylate
20%
Cell Viability
20%
Combination Therapy
20%
Recombinant Protein
20%
Retinoic Acid
20%
Lung Cancer
20%
IC50
20%
Drug Resistance
20%
Enzyme Inhibitor
20%
Acetic Acid Derivative
20%
Retinal
20%
Aldo Keto Reductase
20%
Thiazolidinedione
20%